chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Loss of personal independence in daily activities, Malaise, Pain
Clinical narrative: threw up this morning; tried to go to work but gave out; had to get some rest because she felt dizzy; woke up last night with chills and fever; woke up last night with chills and fever; had aches and pain all over her body; not feeling good at all; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200463386 (Pfizer).  A 57-year-old female patient received bnt162b2 (BNT162B2), administration date 20Mar2022 (Batch/Lot number: unknown) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "she had moderna for her 1st and 2nd dose" (unspecified if ongoing), notes: she had Moderna for her 1st and 2nd dose. The patient's concomitant medications were not reported. Vaccination history included: Moderna (Dose: 1), for COVID-19 Immunization; Moderna (Dose: 2), for COVID-19 Immunization.  The following information was reported: CHILLS (non-serious), PYREXIA (non-serious) all with onset 20Mar2022, outcome "unknown" and all described as "woke up last night with chills and fever"; PAIN (non-serious) with onset 20Mar2022, outcome "unknown", described as "had aches and pain all over her body"; VOMITING (non-serious) with onset 21Mar2022, outcome "unknown", described as "threw up this morning"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 21Mar2022, outcome "unknown", described as "tried to go to work but gave out"; DIZZINESS (non-serious) with onset 21Mar2022, outcome "unknown", described as "had to get some rest because she felt dizzy"; MALAISE (non-serious) with onset Mar2022, outcome "unknown", described as "not feeling good at all".  Additional information: Patient stated that she received the pfizer covid-19 vaccine booster dose at 3 or 4 o'clock on sunday and mentioned she had moderna for her 1st and 2nd dose. She was told by the pharmacist that it's alright to mix. She stated that she woke up last night with chills, fever and also had aches and pain all over her body and threw up this morning. She tried to go to work but gave out. She stated that she had to get some rest because she felt dizzy, and she is not feeling good at all. She also stated that she did not experience this with the first two doses. She wanted to know when the effects will wear out. The case was reported as non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: threw up this morning; tried to go to work but gave out; had to get some rest because she felt dizzy; woke up last night with chills and fever; woke up last night with chills and fever; had aches and pain all over her body; not feeling good at all; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200463386 (Pfizer).  A 57-year-old female patient received bnt162b2 (BNT162B2), administration date 20Mar2022 (Batch/Lot number: unknown) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "she had moderna for her 1st and 2nd dose" (unspecified if ongoing), notes: she had Moderna for her 1st and 2nd dose. The patient's concomitant medications were not reported. Vaccination history included: Moderna (Dose: 1), for COVID-19 Immunization; Moderna (Dose: 2), for COVID-19 Immunization.  The following information was reported: CHILLS (non-serious), PYREXIA (non-serious) all with onset 20Mar2022, outcome "unknown" and all described as "woke up last night with chills and fever"; PAIN (non-serious) with onset 20Mar2022, outcome "unknown", described as "had aches and pain all over her body"; VOMITING (non-serious) with onset 21Mar2022, outcome "unknown", described as "threw up this morning"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 21Mar2022, outcome "unknown", described as "tried to go to work but gave out"; DIZZINESS (non-serious) with onset 21Mar2022, outcome "unknown", described as "had to get some rest because she felt dizzy"; MALAISE (non-serious) with onset Mar2022, outcome "unknown", described as "not feeling good at all".  Additional information: Patient stated that she received the pfizer covid-19 vaccine booster dose at 3 or 4 o'clock on sunday and mentioned she had moderna for her 1st and 2nd dose. She was told by the pharmacist that it's alright to mix. She stated that she woke up last night with chills, fever and also had aches and pain all over her body and threw up this morning. She tried to go to work but gave out. She stated that she had to get some rest because she felt dizzy, and she is not feeling good at all. She also stated that she did not experience this with the first two doses. She wanted to know when the effects will wear out. The case was reported as non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Depressed mood, Heart rate, Heart rate increased, Influenza like illness, Rash
Clinical narrative: pushed me into a very bad low Saturday night; having problem sleeping all day; kind of like flu like symptoms was even worse; heart was racing over 145 beats per minute now wasn't doing anything; Rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (COMIRNATY), administration date 11Mar2022 (Lot number: FK9895) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DEPRESSED MOOD (non-serious) with onset 12Mar2022, outcome "unknown", described as "pushed me into a very bad low Saturday night"; SOMNOLENCE (non-serious) with onset 12Mar2022, outcome "unknown", described as "having problem sleeping all day"; INFLUENZA LIKE ILLNESS (non-serious) with onset 12Mar2022, outcome "unknown", described as "kind of like flu like symptoms was even worse"; HEART RATE INCREASED (non-serious) with onset 12Mar2022, outcome "unknown", described as "heart was racing over 145 beats per minute now wasn't doing anything"; RASH (non-serious) with onset 12Mar2022, outcome "unknown", described as "Rash". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of depressed mood, somnolence, influenza like illness, heart rate increased, rash.  Additional Information: I am calling to report some side effects from Pfizer vaccine, my first shot. I, pushed me into a very bad low Saturday night, got it on Friday the 11th. I was having problem sleeping all day Saturday I was into a low, kind of like flu like symptoms was even worse, my heart was racing over 145 beats per minute now wasn't doing anything. Lasted about a day, now I have a rash. Consumer stated, I do not take any other medication, Young and healthy. Prior vaccination was reported as none.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: pushed me into a very bad low Saturday night; having problem sleeping all day; kind of like flu like symptoms was even worse; heart was racing over 145 beats per minute now wasn't doing anything; Rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (COMIRNATY), administration date 11Mar2022 (Lot number: FK9895) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DEPRESSED MOOD (non-serious) with onset 12Mar2022, outcome "unknown", described as "pushed me into a very bad low Saturday night"; SOMNOLENCE (non-serious) with onset 12Mar2022, outcome "unknown", described as "having problem sleeping all day"; INFLUENZA LIKE ILLNESS (non-serious) with onset 12Mar2022, outcome "unknown", described as "kind of like flu like symptoms was even worse"; HEART RATE INCREASED (non-serious) with onset 12Mar2022, outcome "unknown", described as "heart was racing over 145 beats per minute now wasn't doing anything"; RASH (non-serious) with onset 12Mar2022, outcome "unknown", described as "Rash". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of depressed mood, somnolence, influenza like illness, heart rate increased, rash.  Additional Information: I am calling to report some side effects from Pfizer vaccine, my first shot. I, pushed me into a very bad low Saturday night, got it on Friday the 11th. I was having problem sleeping all day Saturday I was into a low, kind of like flu like symptoms was even worse, my heart was racing over 145 beats per minute now wasn't doing anything. Lasted about a day, now I have a rash. Consumer stated, I do not take any other medication, Young and healthy. Prior vaccination was reported as none.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the parent. A 8 year-old male patient received bnt162b2 (BNT162B2), administration date Feb2022 (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Single), for Covid-19 immunization. The following information was reported: SEIZURE (medically significant) with onset 17Feb2022, outcome "recovered" (17Feb2022), described as "Had a seizure without a fever; 20 hours after the second dose". Therapeutic measures were not taken as a result of seizure. Clinical course: As reported the patient had no adverse effect since 17Feb. The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Fear, Impaired work ability, Mental disorder
Clinical narrative: Felt mental problem/my mind is not working properly; Feeling anonymous fear; Could not work almost four month; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single and administration date Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID", start date: Feb2021 (unspecified if ongoing), notes: I am infected by COVID on Feb2021. The patient's concomitant medications were not reported. The following information was reported: MENTAL DISORDER (non-serious), outcome "unknown", described as "Felt mental problem/my mind is not working properly"; IMPAIRED WORK ABILITY (non-serious) with onset Apr2021, outcome "not recovered", described as "Could not work almost four month"; FEAR (non-serious), outcome "unknown", described as "Feeling anonymous fear".  Additional information: It was reported that patient took Pfizer vaccine of Covid 19 two times and moderna as booster and Pfizer on Apr2021 and booster on Dec of same year. Both time patient felt mental problem. In Apr could not work almost four month and after booster also patient could not work till now properly and feeling anonymous fear and mind is not working properly. Patient was infected by COVID on Feb2021.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test, Vaccination failure
Clinical narrative: No issue until exposed to COVID with travel to (withheld) and Stayed in house with known COVID positive person who was isolating and then ST and AG positive x 2 on 22Mar2022; No issue until exposed to COVID with travel to (withheld) and Stayed in house with known COVID positive person who was isolating and then ST and AG positive x 2 on 22Mar2022; Exposed to COVID; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 02Nov2021 (Lot number: FF2589) at the age of 25 years as dose 3 (booster), single, administration date 17Feb2021 (Lot number: EL3247) as dose 2, single and administration date 28Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 22Mar2022, outcome "unknown" and all described as "No issue until exposed to COVID with travel to (withheld) and Stayed in house with known COVID positive person who was isolating and then ST and AG positive x 2 on 22Mar2022"; EXPOSURE TO SARS-COV-2 (non-serious) with onset 22Mar2022, outcome "unknown", described as "Exposed to COVID". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (22Mar2022) positive, notes: Covid test name post vaccination: Home Ag; (22Mar2022) positive, notes: Covid test name post vaccination: Home Ag. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19, exposure to sars-cov-2.  Clinical course: Facility where the most recent COVID-19 vaccine was administered was workplace clinic. It was unknown if patient receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient diagnosed with COVID-19 prior to vaccination. The patient had been tested for COVID-19 since the vaccination  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on possible temporal association the causal role of BNT162B2 Vaccine cannot be excluded for reported events .Case will be reviewed further on receipt of FU information  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia, SARS-CoV-2 test, Vaccination failure
Clinical narrative: international travel neg Ag preflight 19Mar, then sx 20Mar and positive ag test; international travel neg Ag preflight 19Mar, then sx 20Mar and positive ag test; fever; cough; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 49 year-old male patient received bnt162b2 (BNT162B2), administration date 22Oct2021 (Lot number: FF2589) at the age of 49 years as dose 3 (booster), single, administration date 16Mar2021 (Lot number: EL3247) as dose 2, single and administration date 23Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 20Mar2022, outcome "unknown" and all described as "international travel neg Ag preflight 19Mar, then sx 20Mar and positive ag test"; PYREXIA (non-serious) with onset 20Mar2022, outcome "unknown", described as "fever"; COUGH (non-serious) with onset 20Mar2022, outcome "unknown", described as "cough". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (19Mar2022) negative; (20Mar2022) positive, notes: COVID test type post vaccination: Unknown. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19, pyrexia, cough.  Clinical information: The patient receive any other vaccines within 4 weeks prior to the covid vaccine was unknown, The patient has been tested for covid, since the vaccination and prior to vaccination, the patient diagnosed with covid-19 was unknown   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information in the case, the causal association between the events vaccination failure, COVID-19 and the suspect drug BNT162B2 cannot be excluded.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Thrombosis
Clinical narrative: This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4321893-00 (RA). A 47 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 09Sep2021 (Batch/Lot number: unknown) at the age of 47 years as dose 2, single and intramuscular, administration date 19Aug2021 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for psoriatic arthropathy. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant) with onset 2021, outcome "recovering", described as "Clot blood"; NASOPHARYNGITIS (non-serious), outcome "recovering", described as "Cold". The action taken for adalimumab was unknown. Clinical course: Other Relevant History was Not reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's assessment of the causal relationship of the events with the suspect product was provided at the time of this report. Since possible determination has been received, the case is managed based on the company causality assessment. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, LE cells, LE cells present, Paraesthesia, Sjogren's syndrome
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 51 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SJOGREN'S SYNDROME (medically significant), outcome "unknown", described as "Sjogren's Syndrome"; PARAESTHESIA (non-serious), outcome "recovered", described as "Pins and needles sensation to the left side of her face, in her fingertips, and in her toes that lasted for 3 weeks"; LE CELLS PRESENT (non-serious), outcome "unknown", described as "Tested positive for Lupus (they are still in the process of diagnosing her for it) and Sjogren's Syndrome". The patient underwent the following laboratory tests and procedures: LE cells: positive; antibody test: positive. Since having the vaccine she tested positive for Lupus (they are still in the process of diagnosing her for it) and Sjogren's Syndrome. She states the antibodies for Sjogren's were very low but they were positive. She also states her physician also said that a positive Lupus test doesn't mean she definitely has Lupus. She states she saw a list of conditions on the news that someone reported that were very rare. She is not certain if her symptoms have been caused by the vaccine. Her Neurologist told her about Trigeminal Neuralgia and said she does not have Bell's Palsy. She feels the vaccine triggered all of this. She said the symptoms after the vaccine are different that what is going on now.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysgeusia
Clinical narrative: Metallic taste in mouth continuing after vaccination; Joint pain in knees and elbows-non existent prior to vaccine; This is a spontaneous report from a non-contactable reporter (consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 05Nov2021 (Lot number: FE2590) at the age of 51 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: FE3650; Anatomical location: Left arm), administration date: 11Oct2021, when the patient was 51 years old, for COVID-19 immunisation.  The following information was reported: DYSGEUSIA (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Metallic taste in mouth continuing after vaccination"; ARTHRALGIA (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Joint pain in knees and elbows-non existent prior to vaccine". Therapeutic measures were not taken as a result of dysgeusia and arthralgia.  Additional Information: The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, SARS-CoV-2 test
Clinical narrative: Vaccine abruptly stopped menstruation. Have not had another cycle since I received the vaccine last year.; This is a spontaneous report from a non-contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 23-year-old female patient (not pregnant) received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), administered in right arm (Lot number: unknown) at the age of 22 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. The patient did not receive any concomitant medications. Vaccination history included: Covid-19 vaccine (manufacturer unknown) (DOSE 1; MANUFACTURER UNKNOWN; Anatomical location: Right arm), for COVID-19 immunisation.  The following information was reported: AMENORRHOEA (non-serious) with onset 13Sep2021, outcome "not recovered", described as "Vaccine abruptly stopped menstruation. Have not had another cycle since I received the vaccine last year". The event "Vaccine abruptly stopped menstruation. Have not had another cycle since I received the vaccine last year." was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of amenorrhoea.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicitis perforated
Clinical narrative: This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4325228-00 (RA). A 25 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 31Mar2021 (Batch/Lot number: unknown) at the age of 24 years as dose 2, single for Covid-19 immunisation; Risankizumab (SKYRIZI [RISANKIZUMAB]), subcutaneous (Batch/Lot number: unknown) for psoriasis. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Route of Admin: Intramuscular), administration date: 01Mar2021, when the patient was 24 years old, for Covid-19 Immunization. The following information was reported: APPENDICITIS PERFORATED (prolonged hospitalization, medically significant) with onset 01Jan2022, outcome "recovering", described as "Ruptured appendix". The patient prolonged hospitalization for appendicitis perforated (start date: Jan2022). The action taken for Risankizumab was unknown. Therapeutic measures were taken as a result of appendicitis perforated. Clinical course: Patient was hospitalized for a ruptured appendix at the end of Jan2022, a week after they received COVID booster. They had to remove appendix. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the event(s) of RUPTURED APPENDIX with SKYRIZI (RISANKIZUMAB) was a reasonable possibility. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the event and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Injection site erythema, Injection site pain
Clinical narrative: Severe headache lasting over 24 hours, chills lasting 5 hours, soreness and redness at injection site lasting over 36 hours.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Computerised tomogram, Gait disturbance, Hypoaesthesia, Injection
Clinical narrative: Had numbness in hands, feet and legs that lasted about a week.  Lost feeling in legs while trying to walk down stairs at home.  Almost fell head first down entire flight.  Reached behind me to grab hold of 1/2 wall to stop fall and ended up breaking bone in rotator cuff of rt arm.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Rotator cuff syndrome, X-ray
Clinical narrative: Had numbness in hands, feet and legs that lasted about a week.  Lost feeling in legs while trying to walk down stairs at home.  Almost fell head first down entire flight.  Reached behind me to grab hold of 1/2 wall to stop fall and ended up breaking bone in rotator cuff of rt arm.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Concussion, Dizziness, Eye contusion, Fall, Hypoaesthesia
Clinical narrative: Numbness in hands, feet and leg lasted about a week. Dizziness and blacked-out. Fell multiple times, concussion, black eyes, vertigo and dizziness. Vertigo continues today.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Vertigo
Clinical narrative: Numbness in hands, feet and leg lasted about a week. Dizziness and blacked-out. Fell multiple times, concussion, black eyes, vertigo and dizziness. Vertigo continues today.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: Customer  passed out after the shot. She got her consciouness back in few seconds.Customer refused to get medical attention.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Chills, Diarrhoea, Fatigue, Lethargy
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Diarrhea-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: this adverse event is for shingrx, not covid
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Diarrhea-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: this adverse event is for shingrx, not covid
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Stabbing pains in my back all day long for 3-4 days per week for the first two months. Then, for the next two months, it only happened once a week. Then, for the next two months, it only happened about 1-2 per month. Then it only happened about once a month for the last 4 months to bring us to date. The pain was significant, about a 5 and there was no treatment.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Laboratory test, Multisystem inflammatory syndrome in children
Clinical narrative: Patient was diagnosed with Multisystem Inflammatory Syndrome in child associated with Covid-19.
Age: 32.0
Sex: M
Vaccine: FLU4
Symptoms: Grip strength decreased, Hypoaesthesia, Muscular weakness, Paraesthesia, Peripheral swelling
Clinical narrative: Right arm numbness/tingling, slight right hand swelling,  and weaker grip with right hand. I am able to move my  Right arm, right fingers, and right arm at liberation.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Became allergic to poison ivy for the first time in my life.  One of my doctors also told me the same for him.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Approx 6 hours after the vaccine I had severe chills, body aches and fever lasting approximately 36 hours.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Erythema, Psoriasis
Clinical narrative: I started experiencing a very dry patch on the back of my neck about 1 month after receiving the second dose of the vaccine.  I actually thought it was just dry skin due to the climate that I live in.  I took a small break and went to another climate and it seemed to clear up, upon returning it did progress and my scalp was extremley dry and I had red patches on my neck as well in october but again did not think anything of it.  I finally made a appt to see a dermatologist I was able to seen on March 2, 2022 and was diagnosed with psoriasis.  I do not have any genetic history of this on either side of my family.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Appendicectomy, Appendicitis, Computerised tomogram abdomen abnormal
Clinical narrative: Booster dose given afternoon Monday March 21. Pt woke on Tuesday March 22 at 8 a.m. with RLQ abdominal pain; ER found appendicitis requiring surgical extraction. Pt reported no pain or GI problems prior to Tuesday morning.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: On 3-17-22, the patient came in to get his booster shot.  He mentioned that his arm was sore the next day after the second shot, but then the pain level increased.  He said he had pain from his wrist to the top of his shoulder for about 2 months and then that pain changed from the entire arm to just the top of the shoulder and rotator cuff area.  He was concerned that maybe the shot had been given incorrectly, but he also mentioned that the pain may be related to his job.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Skin papilloma
Clinical narrative: About a month after the vaccine it began to appear as a type of warts on his neck and they have been spreading on his chest and face.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Fall, Head injury, Loss of consciousness, Syncope
Clinical narrative: Brief syncopal event fell and hit head,  immediately regained consciousness, episode was about 1 minute long patient was lying flat on the ground when she regained consciousness
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dizziness, Dyspnoea, Incontinence
Clinical narrative: Within 3 hours started feeling nautilus and light headed, then was violently puking and liquid diarrhea then dry heaving to the point of being incontinent while trying to catch my breathe between episodes could not keep water or bread down for the following 20 hrs when the puking and diarrhea slowed down. Now have aches in my shoulders arms and leg joints, a migraine that is going on for 3 days now, and wooshing ringing in my right ear is very audible
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Retching, Tinnitus, Vomiting
Clinical narrative: Within 3 hours started feeling nautilus and light headed, then was violently puking and liquid diarrhea then dry heaving to the point of being incontinent while trying to catch my breathe between episodes could not keep water or bread down for the following 20 hrs when the puking and diarrhea slowed down. Now have aches in my shoulders arms and leg joints, a migraine that is going on for 3 days now, and wooshing ringing in my right ear is very audible
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Blood test, COVID-19, Condition aggravated
Clinical narrative: - The day after the vaccine I had joint pain and extreme exhaustion. I also remember having a strong headache. -End of Jan I had Covid. Extreme back pain - continually vomited for 12 hours and then went to the hospital for fluids, help me stop vomiting and  pain management. I was prescribed medication to help me continue to not vomit.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Vomiting
Clinical narrative: - The day after the vaccine I had joint pain and extreme exhaustion. I also remember having a strong headache. -End of Jan I had Covid. Extreme back pain - continually vomited for 12 hours and then went to the hospital for fluids, help me stop vomiting and  pain management. I was prescribed medication to help me continue to not vomit.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pyrexia
Clinical narrative: Flu like symptoms, fever, body aches
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Headache, Heavy menstrual bleeding, Insomnia, Menstruation irregular
Clinical narrative: Heavy menses with large clots, irregular cylce, cycle twice as long, menstruated early.  Decreased exercise capacity.  Headaches.  Insomnia.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Oligomenorrhoea
Clinical narrative: Heavy menses with large clots, irregular cylce, cycle twice as long, menstruated early.  Decreased exercise capacity.  Headaches.  Insomnia.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Condition aggravated, Inflammation, Mobility decreased
Clinical narrative: Extreme arthritis. I previously had minor arthritis in a few knuckles. Two weeks after my second vaccine my hands and wrists became extremely inflamed, weak and painful. I could barely use  my use my hands for any activity.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity, Rheumatoid arthritis, Rheumatoid factor positive
Clinical narrative: Extreme arthritis. I previously had minor arthritis in a few knuckles. Two weeks after my second vaccine my hands and wrists became extremely inflamed, weak and painful. I could barely use  my use my hands for any activity.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product administration error
Clinical narrative: Patient was given her 2nd Pfizer vaccine 6 days before the recommended time between first and second dose. Patient has been notified of the vaccine administration error.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Amnestic disorder, Aneurysm, Aneurysm repair, Angiogram cerebral abnormal, Anisocoria
Clinical narrative: Patient found down, unresponsive, pupils unequal, amnestic with delayed responses. Head CT:  Acute hematoma in left thalamus with IVH.  CTA Head/Neck:  Subarachnoid Hemorrhage with hydrocephalous, 1.5 cm saccular aneurysm posterior aspect of basilar tip, 4.5 mm aneurysm left opthalamic artery, 2.5mm infundibulum vs aneurysm at right posterior communicating artery.  Emergently intubated and Right Coronal EVD placed in Neuro Critical Care.  Procedure in Neuro Interventional Radiology:  found 4 total aneurysms.  Returned to NIR on second day for embolization.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arterial disorder, Arteriogram carotid abnormal, Cerebral haematoma, Computerised tomogram head abnormal, Diagnostic procedure
Clinical narrative: Patient found down, unresponsive, pupils unequal, amnestic with delayed responses. Head CT:  Acute hematoma in left thalamus with IVH.  CTA Head/Neck:  Subarachnoid Hemorrhage with hydrocephalous, 1.5 cm saccular aneurysm posterior aspect of basilar tip, 4.5 mm aneurysm left opthalamic artery, 2.5mm infundibulum vs aneurysm at right posterior communicating artery.  Emergently intubated and Right Coronal EVD placed in Neuro Critical Care.  Procedure in Neuro Interventional Radiology:  found 4 total aneurysms.  Returned to NIR on second day for embolization.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Hydrocephalus, Intensive care, Intracranial aneurysm, Intraventricular haemorrhage
Clinical narrative: Patient found down, unresponsive, pupils unequal, amnestic with delayed responses. Head CT:  Acute hematoma in left thalamus with IVH.  CTA Head/Neck:  Subarachnoid Hemorrhage with hydrocephalous, 1.5 cm saccular aneurysm posterior aspect of basilar tip, 4.5 mm aneurysm left opthalamic artery, 2.5mm infundibulum vs aneurysm at right posterior communicating artery.  Emergently intubated and Right Coronal EVD placed in Neuro Critical Care.  Procedure in Neuro Interventional Radiology:  found 4 total aneurysms.  Returned to NIR on second day for embolization.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ophthalmic artery aneurysm, Slow response to stimuli, Subarachnoid haemorrhage, Unresponsive to stimuli, Ventricular drainage
Clinical narrative: Patient found down, unresponsive, pupils unequal, amnestic with delayed responses. Head CT:  Acute hematoma in left thalamus with IVH.  CTA Head/Neck:  Subarachnoid Hemorrhage with hydrocephalous, 1.5 cm saccular aneurysm posterior aspect of basilar tip, 4.5 mm aneurysm left opthalamic artery, 2.5mm infundibulum vs aneurysm at right posterior communicating artery.  Emergently intubated and Right Coronal EVD placed in Neuro Critical Care.  Procedure in Neuro Interventional Radiology:  found 4 total aneurysms.  Returned to NIR on second day for embolization.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Vomiting
Clinical narrative: 13 min after receiving vaccine patient vomitted and complained of abdominal discomfort.  10 minutes after symptoms resolved
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given her 2nd Pfizer vaccine 7 days before the recommended time between the 1st and 2nd dose.
Age: 65.0
Sex: M
Vaccine: UNK
Symptoms: Grip strength decreased, Impaired work ability, Pain, Pain in extremity
Clinical narrative: 66 y/o male here today c/o pain in left arm after 2nd pfizer vaccine injection on May 8 2021. pt has used otc ibuprofen and tylenol daily for pain with TOP diclofenac cream, states it has not provided any relief. pt denies any fall/injury that could of caused pain, states he is sure its from the vaccine. PATIENT STATES THAT AFTER THE FIRST VACCINE WHICH WAS GIVING IN THE SAME ARM HE HAD MINIMAL MUSCLE SORENESS FOR 24 HOURS AND THEN PAIN WENT AWAY COMPLETLEY. HE DID GET THE SECOND SHOT IN THE LEFT ARM AS WELL, AND THE SORENESS BEGAN THAT EVENING, AND GOT PROGRESSIVELY WORSE. HE HAS PAIN ONLY WITH ACTIVE ROM, PAIN IS LOCATED 3-4 FINGER TIPS BELOW THE SHOULDER. THERE IS NO REDNESS, SWELLING, OR LESION NOTED. NO PAIN WITH PALPATION, AND NO PAIN WITH PASSIVE ROM. GRIP IS DECREASED IN THE LEFT HAND. IN THE PAST WEEK HE HAS HAD DIFFICULTY WITH COMPLETING HIS JOB. HE STATES HE RECEIVED THE SECOND VACCINE AT A PHARMACY.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Arthralgia, Fatigue, Nausea
Clinical narrative: severe shoulder pain, nausea, fatigue
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient came in on 10/26/2021 to received 3rd dose immunocompromised Covid Vaccine. Patient should have received Moderna 0.5mL, however received 0.25mL booster dose. Informed patient of this error upon arrival today for their "booster" dose, spoke with medical director. Medical director gave permission to give their 0.5mL dose today and report to VAERS. Patient's father refused to get 0.5mL as he states he is not particularly an advocate for vaccines and would prefer to just receive another half dose (0.25mL). I informed him that this is not recommended by the CDC for immunocompromised patients but he states a little bit is better than none or be given to much.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient given the 2nd Pfizer vaccine 6 days before recommended time between the 1st and 2nd dose.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Aldolase normal, Antibody test negative, Blepharospasm, Blood test normal, Blood thyroid stimulating hormone normal
Clinical narrative: Started with severe cramps in feet and calves for several days, as cramps improved nerve twitching began primarily in the calves of both legs.  As time has progressed the twitching has become worse . . .  always in the calves of the legs,.and is now randomly all over the body including the left lower eyelid, in the scalp above the ears, biceps, mid back, thighs, feet - to name a few.  It occurs daily with the most persistent in the calves of the legs.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count normal, Laboratory test normal, Metabolic function test, Muscle spasms, Muscle twitching
Clinical narrative: Started with severe cramps in feet and calves for several days, as cramps improved nerve twitching began primarily in the calves of both legs.  As time has progressed the twitching has become worse . . .  always in the calves of the legs,.and is now randomly all over the body including the left lower eyelid, in the scalp above the ears, biceps, mid back, thighs, feet - to name a few.  It occurs daily with the most persistent in the calves of the legs.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroxine free normal, Vitamin D
Clinical narrative: Started with severe cramps in feet and calves for several days, as cramps improved nerve twitching began primarily in the calves of both legs.  As time has progressed the twitching has become worse . . .  always in the calves of the legs,.and is now randomly all over the body including the left lower eyelid, in the scalp above the ears, biceps, mid back, thighs, feet - to name a few.  It occurs daily with the most persistent in the calves of the legs.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Medication error, No adverse event
Clinical narrative: no adverse event as of today. Only a medication error
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Diarrhoea, Headache, Injection site nodule
Clinical narrative: Swelling and knot at injection site, sporadic soreness in joints on arm and back(spine)adjacent to injection site, Headache,Diarrhea
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Swelling and knot at injection site, sporadic soreness in joints on arm and back(spine)adjacent to injection site, Headache,Diarrhea
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient came in on 10/26/2021 to received 3rd dose immunocompromised Covid Vaccine. Patient should have received Moderna 0.5mL, however received 0.25mL booster dose. Informed patient of this error upon arrival today for their "booster" dose, spoke with medical director. Medical director gave permission to give their 0.5mL dose today and report to VAERS. Patient refused to get 0.5mL as he states he is not particularly an advocate for vaccines and would prefer to just receive another half dose (0.25mL). I informed him that this is not recommended by the CDC for immunocompromised patients but he states a little bit is better than none or be given to much.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood magnesium, Blood thyroid stimulating hormone, Dizziness, Full blood count
Clinical narrative: Next day after shot, had strong fever/aches/joint pain reaction. Several days later, developed petechiae across trunk and thighs. Went to Facility, saw Dr who prescribed bloodwork to test platelet levels. By the time of the test, platelets were within the normal range, so no treatment was undertaken. Lingering lightheadedness upon standing/headache for about another week.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Metabolic function test, Pain, Petechiae
Clinical narrative: Next day after shot, had strong fever/aches/joint pain reaction. Several days later, developed petechiae across trunk and thighs. Went to Facility, saw Dr who prescribed bloodwork to test platelet levels. By the time of the test, platelets were within the normal range, so no treatment was undertaken. Lingering lightheadedness upon standing/headache for about another week.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count normal, Pyrexia, Red blood cell nucleated morphology, Thyroxine free
Clinical narrative: Next day after shot, had strong fever/aches/joint pain reaction. Several days later, developed petechiae across trunk and thighs. Went to Facility, saw Dr who prescribed bloodwork to test platelet levels. By the time of the test, platelets were within the normal range, so no treatment was undertaken. Lingering lightheadedness upon standing/headache for about another week.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Constipation, Decreased appetite, Dizziness, Gait inability
Clinical narrative: Gulliam Barre   general  weakness  ,numbness all extermities up to the breasts ,unable to  ambulate,w/c  bound. Tahycardia  ,high  blood  pressure,general muscular pain,insomnia,sweats,loose of appetite,constipation,dizziness
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome, Hyperhidrosis, Hypertension, Hypoaesthesia, Insomnia
Clinical narrative: Gulliam Barre   general  weakness  ,numbness all extermities up to the breasts ,unable to  ambulate,w/c  bound. Tahycardia  ,high  blood  pressure,general muscular pain,insomnia,sweats,loose of appetite,constipation,dizziness
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Tachycardia, Wheelchair user
Clinical narrative: Gulliam Barre   general  weakness  ,numbness all extermities up to the breasts ,unable to  ambulate,w/c  bound. Tahycardia  ,high  blood  pressure,general muscular pain,insomnia,sweats,loose of appetite,constipation,dizziness
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: red and sore around injection site one day after injection.  Normal movement of arm not affected
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Rash
Clinical narrative: Next day Totally body rash